. Genomics and Epigenomics Shared Resource - Habtom W. Ressom, PhD, Catalin Marian, MD, PhD The Genomics and Epigenomics Shared Resource (GESR) provides various services including microarray analysis, DNA sequencing, fragment analysis, pyrosequencing, and real-time-polymerase chain reaction (RTPCR) for gene expression and genotyping studies. It also houses user-operated specialized instrumentations for which the shared resource personnel provide technical support and training. The shared resource began in 1984 and has been a CCSG funded facility since 1989. Until recently, this shared resource was called Macromolecular Analysis Shared Resource and provided users with microarray, DNA sequencing, and molecular modeling services as well as several user operated instruments. In 2008, in line with the advances in the field of cancer research and the need for additional genomics and epigenomics services, several instruments that were previously housed in the Carcinogenesis, Biomarkers, and Epidemiology Program were added to the shared resource. The name of the shared resource was also changed to Genomics and Epigenomics to reflect the new direction and services provided. The molecular modeling service was transferred to the more appropriate Drug Discovery Initiative led by Milton Brown, MD, PhD. The objective of GESR is to provide investigators with a wide range of services including: microarray experimental design, array processing, and data analysis; capillary-based fluorescent DNA sequencing and analysis; pyrosequencing DNA analysis for methylation; real-time polymerase chain reaction for genotyping and gene expression analysis; high throughput SNP genotyping; high throughput DNA methylation analysis; next generation sequencing applications (expected in 2009); fluorescence time resolve and fluorescence polarization techniques often used in screening anti-cancer compounds; training and technical support for instruments such as densitometer, bioanalyzer, plate readers, and spectrophotometers. In 2008, the shared resource provided services to 29 investigators from six programs. All but one of these investigators are funded through peer-reviewed grants. Drs. Ressom and Marian are the Directors of the shared resource. Dr. Ressom has been co-directing this shared resource since 2004. He directs the day-to-day operations of the shared resource and provides expertise and tools for analysis and management of genomics and epigenomics data. He facilitates active interactions between Lombardi biostatisticians/bioinformaticians and users to ensure appropriate experimental design, data management and statistical analysis. Dr. Marian has extensive training and experience in molecular genetics and molecular epidemiology. He is in charge of DNA sequencing, RT-PCR applications, genotyping, DNA methylation analyses, and next generation sequencing services. He supervises the day-today activities related to the above mentioned services as well as assisting Lombardi investigators with experimental and assay design.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Georgetown University
United States
Zip Code
Rao, Guanhua; Pierobon, Mariaelena; Kim, In-Kyu et al. (2017) Inhibition of AKT1 signaling promotes invasion and metastasis of non-small cell lung cancer cells with K-RAS or EGFR mutations. Sci Rep 7:7066
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2017) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother :
Vietsch, Eveline E; Graham, Garrett T; McCutcheon, Justine N et al. (2017) Circulating cell-free DNA mutation patterns in early and late stage colon and pancreatic cancer. Cancer Genet 218-219:39-50
Lynce, Filipa; Barac, Ana; Tan, Ming T et al. (2017) SAFE-HEaRt: Rationale and Design of a Pilot Study Investigating Cardiac Safety of HER2 Targeted Therapy in Patients with HER2-Positive Breast Cancer and Reduced Left Ventricular Function. Oncologist 22:518-525
Walker, Logan C; Marquart, Louise; Pearson, John F et al. (2017) Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers. Eur J Hum Genet 25:432-438
Zhang, Yong-Wei; Nasto, Rochelle E; Jablonski, Sandra A et al. (2017) RNA Interference Screening to Identify Proliferation Determinants in Breast Cancer Cells. Bio Protoc 7:
DeVito, Stephen; Woodrick, Jordan; Song, Linze et al. (2017) Mutagenic potential of hypoxanthine in live human cells. Mutat Res 803-805:9-16
Wang, Hongkun; Wang, Ying; Kota, Krishna K et al. (2017) Strong associations between chromosomal aberrations in blood lymphocytes and the risk of urothelial and squamous cell carcinoma of the bladder. Sci Rep 7:13493
Parodi, Daniela A; Greenfield, Morgan; Evans, Claire et al. (2017) Alteration of Mammary Gland Development and Gene Expression by In Utero Exposure to Cadmium. Int J Mol Sci 18:
Casero, David; Gill, Kirandeep; Sridharan, Vijayalakshmi et al. (2017) Space-type radiation induces multimodal responses in the mouse gut microbiome and metabolome. Microbiome 5:105

Showing the most recent 10 out of 997 publications